
Please try another search
Breaking News
By Anisha Sircar and Shashank Nayar
(Reuters) - European shares ended higher on Thursday on hopes fresh curbs and restrictions may not be needed to fight the pandemic going into the new year, but a surge in COVID-19 cases due to the Omicron variant kept a lid on gains.
The pan-European STOXX 600 rose 0.3%, up for the second straight week with the tech sector, healthcare and travel stocks (SXTP), in the lead.
Most European bourses including Germany's DAX, France's CAC40, Spain's IBEX and London's FTSE 100 were on-track to record gains for the second consecutive week.
However, risks of hawkish central banks decisions on rising inflation pressures and lingering concerns of recent jump in global Omicron cases have limited gains so far.
The European Central Bank is close to meeting its 2% medium-term inflation target and can unwind stimulus quicker than planned if price growth continues to surprise on the upside, Dutch central bank chief Klaas Knot told a German newspaper.
"Traders continue to shake off the headlines about the rising number of patients with the omicron variant ... It is worrying that case numbers are high, but the low hospitalisation rates are determining the mood in the markets," said David Madden, an analyst at Equiti Capital.
Spain's IBEX rose 0.5% even as flash data showed consumer prices in December rose 6.7% across the country from the same month last year, the fastest annual pace of inflation since 1989.
The index has underperformed its regional peers in 2021, gaining a near 8%, compared with the STOXX 600's 22% rise.
France's CAC 40 has jumped 29.2% year-to-date, eclipsing the STOXX 600's gains, as hopes of an economic recovery boosted luxury stocks, even though the outlook for demand from Asia remains bleak into the new year.
Graphic:STOXX 600 CAC 40-https://fingfx.thomsonreuters.com/gfx/mkt/dwvkrkgxypm/FINAL%20.EU.png
Global COVID-19 infections hit a record high over the past seven-day period, Reuters data showed on Wednesday, as countries try to fight the pandemic while keeping economies open.
British Prime Minister Boris Johnson said this week he would not bring in new pandemic-related restrictions this year, while a curfew has been ruled out in mainland France.
Researchers said on Thursday a booster dose of Johnson & Johnson (NYSE:JNJ)'s COVID-19 vaccine was 84% effective at preventing hospitalisation in South African healthcare workers who became infected as Omicron spread.
Several European markets including Italy, Germany and Spain will be closed on Friday, while Paris and London will trade for half a session, ahead of the New Year.
(Reuters) -McDonald's Corp will sell its Russian business to its current licensee Alexander Govor and the restaurants would operate under a new brand, the world's largest burger...
By Doyinsola Oladipo (Reuters) -As more people resume travel and plan vacations, retailers and consumer product companies including U.S. discount chain Target and cosmetics...
By Nivedita Balu (Reuters) -Grab Holdings Ltd, Southeast Asia's No. 1 ride-hailing and food delivery firm, on Thursday forecast a rebound in its rideshare and food delivery...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.